Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.
03.02.2022
Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.
03.02.2022 Published by Technology Networks
bit.bio former CEO featured in TechRound
Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.
This Startup Is Making — and Programming — Human Cells
Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
bit.bio CEO features in Charles River's Laboratories Disruptor series
The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.
Takeda oncology vet joins bit.bio as COO
bit.bio Chief Operating Officer Kathryn Corzo featured in Endpoints News.
bit.bio adds $100M+ and members to its board of directors
This feature covers the latest fundraise and appointments to the board.
bit.bio adds $100M+ investments and board of directors
bit.bio adds $100M+ to its coffers and some impressive names to its board of directors.
Florian Schuster features in 300 Years of Leadership and Innovation
The book celebrates leadership and innovation and covers bit.bio's ambition to engineer the future of medicine.
bit.bio featured at London Tech Week 2021
Short film showcases innovative cell reprogramming technology at event.
Loading form…